Anti-IL-9 antibody formulations and uses thereof

Details for Australian Patent Application No. 2005249360 (hide)

Owner MedImmune, LLC

Inventors Allan, Christian B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005249360

PCT Pub. Number WO2005/117967

Priority 60/561,845 12.04.04 US

Filing date 12 April 2005

Wipo publication date 15 December 2005

Acceptance publication date 21 July 2011

International Classifications

C07K 16/06 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - from serum

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/117967 Priority application(s): WO2005/117967

9 October 2008 Alteration of Name

  The name of the applicant has been altered to MedImmune, LLC

21 July 2011 Application Accepted

  Published as AU-B-2005249360

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249363-Phosphonate analogs of HIV integrase inhibitor compounds

2005249359-Phototherapy systems and methods